Paxton Sues Out‑of‑State Provider Accused of Sending Abortion Pills Into Texas

Translate to Spanish or other 102 languages!

In direct violation of Texas law, Her Safe Harbor routinely sends mifepristone and misoprostol to women across state lines. Image for illustration purposes
- Advertisement -

AUSTIN – Attorney General Ken Paxton has filed a lawsuit against Debra Lynch, a Delaware-based nurse practitioner, who operates an extremist group known as Her Safe Harbor that ships abortion drugs into Texas.  

In direct violation of Texas law, Her Safe Harbor routinely sends mifepristone and misoprostol to women across state lines. The organization advertises abortion pills by mail and promises delivery to Texas within days. The lawsuit references a quote from Lynch in which she acknowledges that she and her staff “mail a lot [of abortion drugs] to Texas,” including Beaumont, Fulshear, Tomball, Houston, El Paso, and other major cities that she alludes to. 

This lawsuit follows two tragic cases in Texas in which radical abortion activists and organizations facilitated men illegally purchasing abortion-inducing drugs. According to one lawsuit, a man used the drugs to secretly poison his girlfriend, causing the death of their unborn child, and sending the mother to the hospital. 

- Advertisement -

“The day of reckoning for this radical out-of-state abortion drug trafficker is here,” said Attorney General Paxton. “No one, regardless of where they live, will be freely allowed to aid in the murder of unborn children in Texas.” 

In addition to this lawsuit, Attorney General Paxton has taken legal action against two other abortion drug providers, Plan C and Coeytaux, ordering them to immediately cease promoting, selling, or facilitating the shipment of abortion drugs to Texas residents. 

To read the lawsuit, click here. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -